ALTERITY THERAPEUTICS LTD (ATHE)
HIGH TIDE INC. (HITI)
AECOM (ACM)
AECOM announces planned dates for second quarter fiscal 2026 earnings results and conference call
INGLES MARKETS INC (IMKTA)
Ingles Markets Issues Open Letter to Shareholders
PRUDENTIAL PLC (PUK)
OBOOK HOLDINGS INC. (OWLS)
EQUINOR ASA (EQNR)
UPLAND SOFTWARE, INC. (UPLD)
NOVO NORDISK A S (NVO)
PHARVARIS N.V. (PHVS)
Evidence Supporting Combined Use of Deucrictibant IR with Deucrictibant XR Presented at CIIC Spring 2026 Conference
ANI PHARMACEUTICALS INC (ANIP)
ANI Pharmaceuticals Announces the FDA Approval and Launch of Pimozide Tablets with 180 Day CGT Exclusivity
BLACKSTONE SECURED LENDING FUND (BXSL)
Blackstone Secured Lending Announces First-Quarter 2026 Earnings Release and Conference Call
Merck & Company Inc (MRK)
FDA Grants Priority Review for KEYTRUDA®(pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each with Padcev® (enfortumab vedotin-ejfv), for Cisplatin-Eligible Patients with Muscle-Invasive Bladder Cancer